In 1901, Austrian American immunologist and pathologist while mixing blood of different people made a groundbreaking discovery saving numerous lives and helping the world in creating blood banks, enabling modern surgery and advancing several other fields

In 1901, Austrian American immunologist and pathologist while mixing blood of different people made a groundbreaking discovery saving numerous lives and helping the world in creating blood banks, enabling modern surgery and advancing several other fields. Karl Landsteiner identified the human ABO blood group system after studying what happened when blood samples from different people were mixed. His work explained why some blood transfusions caused dangerous reactions while others could be performed without the same response.

The discovery changed the way doctors understood blood transfusion. Before blood groups were identified, physicians did not have a reliable system for deciding whether blood from one person could be given to another. Transfusions could therefore produce serious reactions. Landsteiner's research showed that blood differs between people and that these differences can cause an immune reaction.

The discovery later became the basis for blood typing and compatible transfusions. It also contributed to the development of blood banks, surgical care, trauma treatment and other areas of medicine. Landsteiner received the Nobel Prize in Physiology or Medicine in 1930 for his discovery of human blood groups.

The blood group discovery that changed transfusion medicine

Karl Landsteiner's work began with a simple laboratory observation. When blood serum from one person was mixed with red blood cells from another person, the cells sometimes clumped together. This process is called agglutination.

Landsteiner investigated these reactions by separating blood into serum and red blood cells and combining samples from different people. He observed that the reactions did not happen with every combination.

These results showed that human blood could be divided into groups based on the reactions between red blood cells and serum. In 1901, Landsteiner identified three groups, which became known as A, B and O. The fourth group, AB, was identified in 1902 by his colleagues Alfred von Decastello and Adriano Sturli.

The basic explanation was linked to structures on red blood cells called antigens and antibodies found in blood serum. When incompatible blood was combined, antibodies could react with antigens on the donor's red blood cells. This could cause the cells to clump. The ABO system therefore provided a way to determine whether blood from two people was compatible.

What is the invention?

The work was not an invention in the usual sense. It was a scientific discovery of the human blood group system. Before Landsteiner's research, doctors knew that blood transfusions could sometimes produce clumping and other reactions. They did not understand the reason for those reactions. Landsteiner established that people have different blood groups. His classification created the foundation for blood typing.

The main groups are:

• A: Red blood cells have A antigens.
• B: Red blood cells have B antigens.
• AB: Red blood cells have both A and B antigens.
• O: Red blood cells do not have A or B antigens.

Blood compatibility depends on the interaction between red-cell antigens and antibodies. This is why doctors need to determine blood type before many transfusions. The ABO system remains a primary part of blood compatibility testing. Rockefeller University notes that more than 200 minor blood groups are now known, but the ABO system remains central to determining compatibility.

How Karl Landsteiner made the discovery?

Landsteiner used blood samples from himself and people working in his laboratory. He separated the serum from the red blood cells and then mixed different combinations.

His observations followed a pattern.

• Some combinations produced clumping.
• Some combinations did not produce clumping.
• The same blood group did not produce the same reaction.
• Different blood groups could produce agglutination.
• These patterns allowed him to classify human blood.

Landsteiner connected the clumping to an immune reaction. The reaction occurred because antibodies in one person's serum could react with antigens on another person's red blood cells.

His 1901 publication provided the basis for understanding blood compatibility. The Nobel presentation later described the 1900 observation of agglutination as the starting point of his blood-group research and noted that the three-group classification followed in 1901.

Why was the blood group system needed?

Early blood transfusions were not based on a modern compatibility system. A person's blood could look similar to another person's blood, but the biological properties were not necessarily the same. When incompatible blood was transfused, the recipient could develop a serious reaction. Landsteiner's discovery explained why these reactions happened.

The discovery gave doctors a method to identify blood types before transfusion. This reduced the risk associated with incompatible blood. The first successful transfusions using blood typing followed in the years after the discovery. Rockefeller University records that Reuben Ottenberg performed the first successful transfusions in 1907 and that blood-typing tests were being used by 1910.

Who was Karl Landsteiner?

Karl Landsteiner was born on June 14, 1868, in Vienna, then part of the Austrian Empire. He studied medicine at the University of Vienna and received his medical degree in 1891. His father, Leopold Landsteiner, was a journalist and editor and died when Karl was six. His mother was Fanny Hess Landsteiner.

After medical school, Landsteiner studied chemistry in European laboratories. He worked with scientists including Emil Fischer. This training helped him combine chemistry with medical research.

After returning to Vienna, he worked with Max von Gruber at the Hygiene Institute. He later worked in the department of pathological anatomy at the University of Vienna. His work involved immunity, antibodies, blood and disease. These areas helped him develop the research approach that led to the ABO discovery.

Landsteiner later moved to the United States. In 1922, he joined the Rockefeller Institute for Medical Research in New York, where he continued studying blood antigens and immune reactions. He retired in 1939 but continued working on research. He died in New York on June 26, 1943.

How did the discovery help the world?

The ABO blood group system changed medical practice in several ways.

It reduced dangerous transfusion reactions

Doctors could determine blood groups before transfusion rather than relying on trial and error. This helped prevent reactions caused by incompatible blood.

It supported modern surgery

Surgery can involve blood loss. The ability to give compatible blood made procedures involving significant blood loss more practical. Rockefeller University notes that the development of transfusion methods helped make surgery on internal organs possible during the early 20th century.

It supported trauma care

Patients who lose blood because of accidents or injuries can require transfusion. Blood typing provided the basis for selecting compatible blood.

It helped create blood banks

The discovery was followed by developments in blood storage and organized transfusion services. Rockefeller University records that blood banks were established in the 1930s. Earlier work also showed that adding citrate could prevent coagulation and allow stored blood to be kept under refrigeration for a period of time.

It supported blood donation systems

Once blood could be classified and stored, hospitals and medical organizations could develop systems for collecting, testing and distributing blood.

It contributed to genetics and forensic science

Blood groups became useful in studying inheritance. By 1910, researchers had proposed the inheritance of blood groups. The ABO system was later used in legal cases involving questions of paternity.

Nobel Prize and scientific legacy

Landsteiner received the Nobel Prize in Physiology or Medicine in 1930 for his discovery of human blood groups. The Nobel Committee described the discovery as important for medical science and practical medicine. His work became a foundation of transfusion medicine. The ABO system is still used in blood testing today.

Landsteiner's research also showed how a laboratory observation can lead to changes in medical practice. A reaction seen after mixing blood samples became the basis for understanding blood compatibility.

His research helped establish the principle that blood cannot be treated as identical between all people. Identifying the differences made it possible to test, match and transfuse blood with greater control. The effects reached beyond transfusion medicine. Blood-group research contributed to immunology, genetics, forensic work and the study of antigen-antibody reactions.